Apellis Pharmaceuticals
APLS
APLS
246 hedge funds and large institutions have $2.28B invested in Apellis Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 108 increasing their positions, 69 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 49
18% less capital invested
Capital invested by funds: $2.77B → $2.28B (-$489M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
246
Holding in Top 10
4
Calls
$56.2M
Puts
$12.6M
Top Buyers
| 1 | +$46.4M | |
| 2 | +$34.6M | |
| 3 | +$32.9M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.3M |
| 5 |
Amundi
Paris,
France
|
+$22.7M |
Top Sellers
| 1 | -$57.6M | |
| 2 | -$25.7M | |
| 3 | -$22.5M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$20.6M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$17.1M |
